Systemic corticosteroids and folic acid antagonists in the treatment of generalized pustular psoriasis. Evaluation and prognosis based on the study of 104 cases

Br J Dermatol. 1969 Feb;81(2):134-45. doi: 10.1111/j.1365-2133.1969.tb15995.x.
No abstract available

MeSH terms

  • Adrenal Cortex Hormones / adverse effects
  • Adrenal Cortex Hormones / therapeutic use*
  • Adrenocorticotropic Hormone / therapeutic use
  • Adult
  • Age Factors
  • Aged
  • Betamethasone / therapeutic use
  • Dexamethasone / therapeutic use
  • Female
  • Folic Acid Antagonists / therapeutic use*
  • Humans
  • Hydrocortisone / therapeutic use
  • Male
  • Methotrexate / adverse effects
  • Methotrexate / therapeutic use
  • Middle Aged
  • Paramethasone / therapeutic use
  • Prednisolone / therapeutic use
  • Prognosis
  • Psoriasis / drug therapy*
  • Psoriasis / mortality
  • Triamcinolone / therapeutic use

Substances

  • Adrenal Cortex Hormones
  • Folic Acid Antagonists
  • Triamcinolone
  • Dexamethasone
  • Adrenocorticotropic Hormone
  • Betamethasone
  • Prednisolone
  • Paramethasone
  • Hydrocortisone
  • Methotrexate